Applications for remaining time slots for DCP (with Latvia acting as RMS) s in 2027 will open on 4 August 2026 – January 1 slot, July – 1 slot, September – 1 slot, October – 1 slot.
The Agency has reviewed the applications for booking DCP procedure time slots (Latvia as RMS) that were received on 15 July 2026 and has informed the respective applicants whether their applications were approved or rejected. As a result, registration for the remaining available slots can now be opened.
Applicants are kindly requested to act responsibly and reserve a submission slot only when it is certain that the marketing authorisation application will be fully prepared and submitted within the reserved timeframe.
The Agency also reserves the right to refuse a time-slot reservation in cases where an applicant frequently requests changes to the medicinal product covered by an already approved reservation or fails to submit the planned registration application.
More detailed information on the time slot booking tool for submission of medicinal product authorization applications is available here: https://www.zva.gov.lv/en/news-and-publications/news/time-slot-allocation-tool-dcp-lv-rms-and-national-marketing-authorisation-procedure
